U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07838129) titled 'Evaluation of Corneal Endothelium Health Following Articaine Ophthalmic Solution Administration' on Sept. 18.

Brief Summary: The goal of this clinical trial is to evaluate the corneal endothelium health of eyes treated with articaine ophthalmic solution in adult participants.

Study Start Date: Jan., 2027

Study Type: INTERVENTIONAL

Condition: Healthy Cornea

Intervention: DRUG: Articaine (CYKLX)

Two drops of Articaine administered sequentially to the study eye.

DRUG: Vehicle

Two drops of Vehicle administered sequentially to the study eye.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Laboratoires Thea

Published by HT Di...